3-179198938-G-A
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_ModeratePP5_Moderate
The NM_006218.4(PIK3CA):c.113G>A(p.Arg38His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,459,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R38C) has been classified as Uncertain significance.
Frequency
Consequence
NM_006218.4 missense
Scores
Clinical Significance
Conservation
Publications
- overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- megalencephaly-capillary malformation-polymicrogyria syndromeInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- vascular malformationInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden syndrome 5Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 248664 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1459198Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726004 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes Pathogenic:1
This sequence change in PIK3CA is predicted to replace arginine with histidine at codon 38, p.(Arg38His). The arginine residue is highly conserved (100 vertebrates, Multiz Alignments), and is located in adaptor binding domain (PI3K ABD) a region, amino acids 31-108, that is defined as a mutational hotspot. There is a small physicochemical difference between arginine and histidine. PIK3CA , in which the variant was identified, is a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (gnomAD v2.1). The highest population minor allele frequency in the population database gnomAD v4.0 is 0.0002% (2/1,110,018 alleles) in the European (non-Finnish) population. This variant has been detected in at least one individual with polymicrogyria (Melbourne Health Pathology) and has been reported as a somatic event in at least 40 tumour samples (COSMIC ID: COSV55879949). In vitro functional studies assessing kinase activity (with limited assay validation) demonstrate a gain of function effect for the variant which is weaker than well-established pathogenic gain of function variants (PMID: 15930273, 16339315, 17376864). Computational evidence predicts a deleterious effect for the missense substitution (REVEL = 0.654). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as LIKELY PATHOGENIC. Following criteria are met: PS4_Moderate, PM1_Supporting, PM2_Supporting, PP2, PP3, PS3_Supporting. -
Neoplasm Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at